Table 1.
Demographic and clinical characteristics of study participants.
| Characteristic | Lung adenocarcinoma patient | P-value | |
|---|---|---|---|
| CPSP | non-CPSP | ||
| Sex, n (%) | 0.588 | ||
| Male | 22 (42.30) | 45 (52.94) | |
| Female | 30 (57.69) | 40 (47.06) | |
| Age, n (%) | 0.098 | ||
| <60 years | 35 (67.31) | 45 (52.94) | |
| ≥60 years | 17 (32.69) | 40 (47.06) | |
| Body mass index | 24.41 ± 3.29 | 22.69 ± 2.55 | <0.001 |
| History of chronic pain | 0.021 | ||
| No | 37 (71.15) | 74 (87.06) | |
| Yes | 15 (28.85) | 11 (12.94) | |
| Surgery duration (minutes) | 207.21 ± 78.59 | 187.76 ± 74.24 | 0.148 |
| Drainage time (days) | 3.77 ± 1.57 | 3.40 ± 0.73 | 0.115 |
| Hospitalization time (days) | 4.87 ± 1.58 | 4.42 ± 0.75 | 0.065 |
| miRNA146a | 1.57 ± 2.89 | 2.35 ± 4.01 | 0.225 |
| miRNA550a | 1.90 ± 1.47 | 1.25 ± 0.81 | 0.001 |
| miRNA3613 | 1.38 ± 0.76 | 1.19 ± 0.79 | 0.174 |
| VAS1d | 3.54 ± 1.38 | 2.94 ± 1.148 | 0.007 |
| VAS2d | 2.96 ± 1.20 | 2.35 ± 0.10 | 0.002 |
| VAS3d | 2.15 ± 1.04 | 1.78 ± 0.76 | 0.016 |
| Pittsburgh Sleep Quality Index | 5.38 ± 4.15 | 6.28 ± 3.63 | 0.186 |
| State–Trait Anxiety Inventory | 29.48 ± 6.66 | 30.55 ± 7.14 | 0.383 |
CPSP, chronic postsurgery pain; VAS, visual analog scale.